Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Five Year Outcomes

: These results suggest that early DBS reduces the need for and complexity of PD medications while providing long-term motor benefit over standard medical therapy. Further investigation is warranted, and the FDA has approved the conduct of a prospective, multicenter, pivotal clinical trial of DBS in early-stage PD.